title: Single agents or combination chemotherapy for advanced ovarian carcinoma in elderly patients: pro single agents.
authors: Divisione di Oncologia Medica B, Istituto Nazionale Tumori, Fondazione G Pascale, Naples.
authors: Sandro
authors: S
authors: Pignata
authors: Massimo
authors: M
authors: Di Maio
authors: Alessandro
authors: A
authors: Ottaiano
authors: Ermelinda
authors: E
authors: De Maio
authors: Emiddio
authors: E
authors: Barletta
authors: Carmela
authors: C
authors: Pisano
authors: Rosa
authors: R
authors: Tambaro
mesh_terms: D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D016190:Carboplatin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D015897:Comorbidity; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D012189:Retrospective Studies
chemical_list: D000970:Antineoplastic Agents; D016190:Carboplatin